Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Depreciation & Amortization (CF) (2016 - 2025)

Avalo Therapeutics filings provide 12 years of Depreciation & Amortization (CF) readings, the most recent being $16000.0 for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 76.47% to $16000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $344000.0, a 103.55% increase, with the full-year FY2025 number at $344000.0, up 103.55% from a year prior.
  • Depreciation & Amortization (CF) hit $16000.0 in Q4 2025 for Avalo Therapeutics, down from $59000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $456000.0 in Q2 2021 to a low of $16000.0 in Q4 2025.
  • Median Depreciation & Amortization (CF) over the past 5 years was $42000.0 (2023), compared with a mean of $124700.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): plummeted 93.42% in 2022 and later soared 306.06% in 2025.
  • Avalo Therapeutics' Depreciation & Amortization (CF) stood at $295000.0 in 2021, then tumbled by 88.14% to $35000.0 in 2022, then grew by 22.86% to $43000.0 in 2023, then skyrocketed by 58.14% to $68000.0 in 2024, then tumbled by 76.47% to $16000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $16000.0 (Q4 2025), $59000.0 (Q3 2025), and $134000.0 (Q2 2025) per Business Quant data.